Mergers and Acquisitions in the Pharma Industry
4 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Andre Menard from Trade unions and social activism
Scoop.it!

Britain Accuses GlaxoSmithKline of Conspiring With Rivals Over Generics

Britain Accuses GlaxoSmithKline of Conspiring With Rivals Over Generics | Mergers and Acquisitions in the Pharma Industry | Scoop.it
The antitrust authorities have accused GlaxoSmithKline of paying three competitors to delay the introduction of a generic version of an antidepressant drug.

Via Leicester Worker
Andre Menard's insight:

Surprised that more big name companies are not doing this. "Big Pharma" companies are getting killed by generics therefore I could see this being an issue in the future as more and more patents expire and the Big Pharma companies bottom lines decrease.

more...
No comment yet.
Rescooped by Andre Menard from Pharma & Medical Devices
Scoop.it!

Are generics really the same as branded drugs? - Fortune Management

Are generics really the same as branded drugs? - Fortune Management | Mergers and Acquisitions in the Pharma Industry | Scoop.it
Consumers are told that generics are just like their name-brand counterparts.  More medical professionals are starting to say that's not the case.

Via Richard Meyer
Andre Menard's insight:

Very interesting article...80% of drugs sold in the US were generic! I found that figure to be very high, but regardless the difference between the original and generic is not discussed as much as I would have thought. People seem to only be concerned about a cheaper product, not if the product is going to do what it is supposed to.

more...
No comment yet.
Scooped by Andre Menard
Scoop.it!

Pfizer will allow Teva to sell generic Viagra - Reuters India

Pfizer will allow Teva to sell generic Viagra - Reuters India | Mergers and Acquisitions in the Pharma Industry | Scoop.it
Financial Express Pfizer will allow Teva to sell generic Viagra Reuters India (Reuters) - Pfizer Inc on Tuesday said it would allow Teva Pharmaceutical Industries to sell generic forms of its Viagra anti-impotence treatment in the United States...
Andre Menard's insight:

Smart move by Pfizer instead of a large portion of revenue once the patent expires, they will recieve royaties from Teva and lessen the blow of losing a billion dollar drug to a generic market completely. Teva in turn will be the generic first mover by being allowed to release generic version of Viagra before the other generi companies. 

more...
No comment yet.
Scooped by Andre Menard
Scoop.it!

Cardinal, CVS to form venture for generics

Cardinal, CVS to form venture for generics | Mergers and Acquisitions in the Pharma Industry | Scoop.it
Cardinal Health is joining forces with CVS Caremark to buy generic drugs worldwide to sell in the U.S. market, a move that’s expected to add to both companies’ bottom lines and put them on equal footing with competitors.
Andre Menard's insight:

Interested to see if more pharmacies do the same and follow CVS.

more...
No comment yet.
Scooped by Andre Menard
Scoop.it!

Article > India: exports of generics growing 24% a year - PharmaTimes

Article > India: exports of generics growing 24% a year - PharmaTimes | Mergers and Acquisitions in the Pharma Industry | Scoop.it
India's exports of generics have been growing at a rate of 24% per year over the last four years, and are set to continue this "explosive growth," an international conference has been told. India's pharmaceutical exports for ...
Andre Menard's insight:

Going to be difficult for American and other countries generic companies to keep up with Indias growth. 

more...
No comment yet.
Scooped by Andre Menard
Scoop.it!

Torrent Pharma to buy Elder's India business - Business Standard

Torrent Pharma to buy Elder's India business
Business Standard
Though MNCs are keen on formulation business in India, issues such as lack of patent protection and pricing cap pull them back from going for expensive buyouts nowadays.
Andre Menard's insight:

India continuing to make moves in the pharma industry.

more...
No comment yet.